Company’s Stem Cell Treatment Shown Effective In Rat Study Of Neurodegenerative Diseases

November 17, 2009

BrainStorm Cell Therapeutics Inc. of Petach Tikvah, Israel, (BCLI) said on November 9 that its stem cell technology was shown to be more effective than mesenchymal stem cells in treating neurodegenerative diseases in rat studies.

In a scientific paper published in the Israel Medical Association Journal, show the migratory capacity of Neurotrophic Factor Stem Cells (NTF-SC) in rat models of Parkinson’s disease and Huntington disease.

To read the full story, please click on the following link:

http://www.stemcellresearchnews.com/absolutenm/anmviewer.asp?a=1903&z=9

Advertisements

One Response to “Company’s Stem Cell Treatment Shown Effective In Rat Study Of Neurodegenerative Diseases”

  1. Very interesting. A lot of research has historically taken place in Israel, yes, and also Japan. I know this because I have visited The National Parkinson Foundation in Miami several times and researchers enthusiastically bring their data there to share and exchange with other medical researchers on the U of M campus. Excellent!

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: